Index. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.

Size: px

Start display at page:

Download "Index. derm.theclinics.com. Note: Page numbers of article titles are in boldface type."

Joanna Adams
5 years ago
Views:

1 Index Note: Page numbers of article titles are in boldface type. A AAD. See American Academy of Dermatology. Abscesses Acetaminophen and dengue fever, 36 Acquired immunodeficiency syndrome. See Human immunodeficiency virus. Aedes aegypti and dengue fever, 33 and yellow fever, Africa albinism in, female genital mutilation in, 105 skin lightening compounds in, 116 Albinism and assistance and awareness organizations, 83 awareness campaigns in Africa, myths and misconceptions in Africa, and needs for improved survival, 82 and ocular disorders, 81 proposed solutions in Africa, 85 and slaughter in Africa, 79, and solar skin damage, 81 Albinism in Africa: Stigma, slaughter and awareness campaigns, Aloha Medical Mission and Mycobacterium marinum on Satowan, 11 American Academy of Dermatology s Resident International Grant history of, 64 and resident responsibilities, American trypanosomiasis. See Chagas disease. AMM. See Aloha Medical Mission. Antimibrobial peptides Antimicrobial agents Arboviruses mosquito-borne infections related to, 34 Arsenic and basal cell carcinoma, 46, 48 contamination of drinking water, and skin cancer, and squamous cell carcinoma, Arsenical keratoses and iquimod, 48 of the palms, 46 Dermatol Clin 29 (2011) doi: /s (10) /11/$ see front matter Ó 2011 Elsevier Inc. All rights reserved. Arsenical keratoses in Bangladesh Update and prevention strategies, Arsenicosis cutaneous disease, differential diagnosis for, 47 laboratory findings of, 48 malignant disease, management and prevention of, nonmalignant and premalignant disease, 46 risk factors for, 48 B Bacille Calmette-Guérin and Buruli ulcer, 2 and Leishmania, 93 Bangladesh arsenical keratoses in, Basal cell carcinoma and arsenic, 46, 48 BCC. See Basal cell carcinoma. BCG. See Bacille Calmette-Gue rin. Benznidazole and Chagas disease, Blood transfusion and Chagas disease, 53 Bomb craters and Mycobacterium marinum on Satowan, Botswana dermatology in, BU. See Buruli ulcer. Bunyaviridae and mosquito-borne hemorrhagic fevers, 34 Buruli ulcer and bacille Calmette-Guérin vaccination, 2 classification and natural history of, 4 distribution by country, 3 epidemiology of, 1 2 plaque of, 2 rifampin plus streptomycin for, 5 Buruli ulcer: Advances in understanding Mycobacterium ulcerans infection, 1 8 C C3. See Complement 3. CA-MRSA. See Community-associated methicillin-resistant Staphylococcus aureus Chagas disease and benznidazole, clinical presentation of, derm.theclinics.com

2 130 Index Chagas (continued) diagnosis and evaluation of, epidemiology and economic effect of, 54 food-borne, 54 gastrointestinal complications of, 56 and heart disease, and human immunodeficiency virus, 56 mucocutaneous manifestations of, 55 and nifurtimox, prevention and control of, 58 transmission of, transmitted by blood transfusion, 53 transmitted by Rhodnius prolixus, 53 transmitted by transplantation, transmitted by Triatoma dimidiata, 53 transmitted by Triatoma infestans, 53 transmitted by Triatominae, 53 transplacental transmission, 54 treatment of, and Trypanosoma cruzi, Chagas disease: Coming to a place near you, Clindamycin Staphylococcus aureus, Clitoridectomy and female genital mutilation, 104 Common childhood skin disorders assessment algorithm for, 25 modified WHO integrated management of, 26 Community-associated methicillin-resistant Staphylococcus aureus antimicrobial agents for, 24 clindamycin for, and decolonization efforts, 27 diagnosis of, disinfecting agents for, 24 dominant clones in tropical regions, 22 doxycycline for, and drainage of abscesses, 24 epidemiology of, and fusidic acid, 24 and gentian violet, 24 and impetigo, 23 24, 26 linezolid for, and management of community outbreaks, 27 and mupirocin, 24 oral antibiotics for, and poor living conditions, 23 predisposing factors to, 23 and scabies infestation, 23 skin and soft tissue infections caused by, and Streptococcus pyogenes, 22 23, topical treatments for, 24 treatment of, trimethoprim-sulfamethoxazole for, 26 in the United States, 22 and vancomycin, 27 Community-associated methicillin-resistant Staphylococcus aureus skin infections in the tropics, Complement 3 Conjunctival hemorrhages in dengue fever, 35 Contact dermatitis aboard the USNS Comfort in Haiti, 17 Cutaneous leishmaniasis innate immunity and vaccination strategies, in Mali, Cutaneous leishmaniasis in Mali, D DC. See Dendritic cells. Decolonization Staphylococcus aureus, 27 Deinfibulation and female genital mutilation, 106 Dendritic cells and immunity to Leishmania, 95 Dengue fever, and acetaminophen, 36 and Aedes aegypti, 33 clinical presentation of, complementary tests for, conjunctival hemorrhages in, 35 diagnosis of, erythema in, 35 hemorrhagic, and hydration, 36 morbilliform eruption of, 34 palmar edema in, 35 treatment and prevention of, 36 Dengue hemorrhagic fever, disseminated petechiae in, 35 Dermatology aboard the USNS Comfort: Disaster relief operations in Haiti after the 2010 earthquake, Dermatology education and the American Academy of Dermatology s Resident International Grant, 64 Dermatology in Botswana: The American Academy of Dermatology s Resident International Grant, Dermatophyte infections aboard the USNS Comfort in Haiti, 17 DF. See Dengue fever. DHF. See Dengue hemorrhagic fever. Disaster relief in Haiti and dermatology aboard the USNS Comfort, Disinfecting agents

3 Index 131 Disseminated petechiae in dengue hemorrhagic fever, 35 Doxycycline Staphylococcus aureus, E Earthquake EDV. See Epidermodysplasia verruciformis. Effectiveness of gentian violet and similar products commonly used to treat pyodermas, Epidermodysplasia verruciformis aboard the USNS Comfort in Haiti, 18 Erythema in dengue fever, 35 Excision and female genital mutilation, 104 Exogenous ochronosis and skin lightening compounds, F Female circumcision. See Female genital mutilation. Female genital mutilation in Africa, 105 classification of, 104 and clitoridectomy, 104 and deinfibulation, 106 dermatologic complications of, epidemiology and prevalence of, and excision, 104 and human immunodeficiency virus, 103, and infibulation, 104 legal and social issues regarding, 107 Female genital mutilation: What every American dermatologist needs to know, FGM. See Female genital mutilation. Flaviviridae and mosquito-borne hemorrhagic fevers, 34 and yellow fever, 36 Fusidic acid G Gentian violet and pyodermas, and related compounds, 73 GV. See Gentian violet. H HAART. See Highly active antiretroviral therapy. Haiti disaster relief in, HAM. See Humanitarian assistance mission. Heart disease and Chagas disease, Hemorrhagic fevers mosquito-borne, Highly active antiretroviral therapy effect on human immunodeficiency virus and leprosy coinfection, and immune reconstitution inflammatory syndrome, Human immunodeficiency virus and Chagas disease, 56 and epidermodysplasia verruciformis, 18 and female genital mutilation, 103, and immune reconstitution inflammatory syndrome, and leprosy, Human immunodeficiency virus and leprosy: What is the latest? Human immunodeficiency virus and leprosy coinfection effect of antiretroviral therapy on, and immune reconstitution inflammatory syndrome, immunology of, 126 Human rights and female genital mutilation, Humanitarian assistance mission Hydration and dengue fever, 36 Hydroquinone as a skin lightening compound, Hyperpigmentation and skin lightening compounds, I Immune reconstitution inflammatory syndrome and human immunodeficiency virus and leprosy coinfection, Immune reconstitution inflammatory syndrome and tropical dermatoses, Immune restoration disease. See Immune reconstitution inflammatory syndrome. Immunity to Leishmania and antimibrobial peptides, 97 and basic host mechanisms, 90 and complement 3, 97 and dendritic cells, 95 and induction of nitric oxide synthase, 97 and macrophage receptor with collagenous structure, 97

4 132 Index Immunity (continued ) and macrophages, 94 and mast cells, 95 and natural killer cells, 95 and neutrophils, 94 and persistent parasites after clinical resolution, 91 role of innate immune system in, role of Toll-like receptors in, 90, and suppressors of cytokine signaling, 97 Th1-Th2 role in, and Toll-like receptors, 96 Immunization for yellow fever, 37 Impetigo Staphylococcus aureus, 23 24, 26 India skin lightening compounds in, Induction of nitric oxide synthase Infibulation and female genital mutilation, 104 Innate immunity and Leishmania, Innate immunity and Leishmania vaccination strategies, inos. See Induction of nitric oxide synthase. Iquimod and arsenical keratoses, 48 IRIS. See Immune reconstitution inflammatory syndrome. Island psoriasis. See Mycobacterium marinum. K Keratoses arsenical, L Leishmania and bacille Calmette-Guérin, 93 immunity to, and subversion of immune system, 98 vaccines for, Leishmania major and leishmaniasis, 41, Leishmaniasis epidemiology of, 76 in Mali, and rodents as reservoirs of infection, 77 transmitted by Phlebotomus, 77 transmitted by sand flies, 77 transmitted by Sergentomyia, 77 vaccine usefulness for, vector of, 77 Leprosy and human immunodeficiency virus, 40, and multidrug therapy, 40 Linezolid Staphylococcus aureus, M Macrophage receptor with collagenous structure Macrophages and immunity to Leishmania, 94 Mali cutaneous leishmaniasis in, MARCO. See Macrophage receptor with collagenous structure. Mast cells and immunity to Leishmania, 95 Mercurials as skin lightening compounds, 112, Mercury poisoning and skin lightening compounds, , 117 Methicillin-resistant Staphylococcus aureus and pyodermas, skin infections in the tropics, Morbilliform eruption of dengue fever, 34 Mosquito-borne hemorrhagic fevers, and arboviruses, 34 and Bunyaviridae, 34 and Flaviviridae, 34 and Togaviridae, 34 MRSA. See Methicillin-resistant Staphylococcus aureus. Mupirocin Murder of albinos in Africa, 79, Mycobacterial disease nontuberculous, 9 13 Mycobacterium leprae and leprosy, 40, Mycobacterium marinum investigation of disease on Satowan, plaques of, 10 Mycobacterium ulcerans, 1 8 clinical features and diagnosis of, 4 5 insects as vectors of, 2 microbiology of, 2 4 pathogenesis and immunity to, 4 treatment of, 5 6 Mycolactone and Buruli ulcer, 1 5

5 Index 133 N Natural killer cells and immunity to Leishmania, 95 Neutrophils and immunity to Leishmania, 94 Nifurtimox and Chagas disease, NK cells. See Natural killer cells. Nontuberculous mycobacterial disease on Satowan, 9 13 North America skin lightening compounds in, 117 NTM. See Nontuberculous mycobacterial disease. O OCA. See Oculocutaneous albinism. Ocular disorders and albinism, 81 Oculocutaneous albinism in Africa, Operation Unified Response Oral antibiotics 27 Oryzias latipes and Mycobacterium marinum on Satowan, 12 Outbreak of nontuberculous mycobacterial disease in the Central Pacific, 9 13 P Pacific Islanders nontuberculous mycobacterial disease among, 9 13 Palmar edema in dengue fever, 35 Parasites vaccinations for, 89 Penicilliosis Penicillium marneffei and penicilliosis, 41 Phlebotomus and leishmaniasis, 77 Poisoning by drinking water contamination with arsenic, Pyodermas and alternatives to gentian violet, and gentian violet, and methicillin-resistant Staphylococcus aureus, and reducing vascular leak, R and skin and soft tissue infections, and triphenylmethanes, and Weibel-Palade bodies, 72 Rhodnius prolixus Rifampin for Buruli ulcer, 5 S Sand flies and leishmaniasis, 77, 97 Satowan geography and history of, 9 11 nontuberculous mycobacterial disease on, 9 13 Scabies Staphylococcus aureus, 23 SCC. See Squamous cell carcinoma. Sergentomyia and leishmaniasis, 77 Skin and soft tissue infections caused by community-associated methicillin-resistant Staphylococcus aureus, and pyodermas, Skin cancer and arsenic, Skin lightening compounds adverse effects of, in Africa, 116 alternatives to, and exogenous ochronosis, hydroquinone, and hyperpigmentation, in India, medical use of, mercurials, 112, and mercury poisoning, , 117 in North America, 117 psychosociologic aspects of, topical corticosteroids, 112, 114 SOCS. See Suppressors of cytokine signaling. Solar skin damage and albinism, 81 Spam. See Mycobacterium marinum. Sporothrix schenckii and sporotrichosis, 41 Sporotrichosis Squamous cell carcinoma and arsenic, SSTI. See Skin and soft tissue infections. Staphylococcus aureus

6 134 Index Staphylococcus (continued) community-associated methicillin-resistant, vaccination against, Streptococcus pyogenes Staphylococcus aureus, 22 23, Streptomycin for Buruli ulcer, 5 Strongyloidiasis Suppressors of cytokine signaling T Taro farming and Mycobacterium marinum on Satowan, 11 TC. See Topical corticosteroids. Teledermatology and dermatology in Botswana, Tinea infections aboard the USNS Comfort in Haiti, 17 TLR. See Toll-like receptors. Togaviridae and mosquito-borne hemorrhagic fevers, 34 Toll-like receptors and immunity to Leishmania, 96 Topical corticosteroids as skin lightening compounds, 112, 114 Transplantation and Chagas disease, Triatoma dimidiata Triatoma infestans Triatominae Trimethoprim-sulfamethoxazole Staphylococcus aureus, 26 Triphenylmethanes and pyodermas, Tropical dermatology, 21 28, 39 41, 63 67, Tropics community-associated methicillin-resistant Staphylococcus aureus in, Trypanosoma cruzi and Chagas disease, U USNS Comfort physician/staff specialties aboard, 16 V Vaccination against Staphylococcus aureus, Vancomycin Staphylococcus aureus, 27 Vascular leak in pyodermas, Viral hemorrhagic fevers mosquito-borne, Volunteerism and dermatology in Botswana, W Weibel-Palade bodies and pyodermas, 72 Widespread use of toxic skin lightening compounds: Medical and psychosociologic aspects, WPB. See Weibel-Palade bodies. X Xeroderma pigmentosum aboard the USNS Comfort in Haiti, XP. See Xeroderma pigmentosum. Y Yellow fever, and Aedes aegypti, clinical manifestations of, 37 diagnosis of, 37 and Flaviviridae, 36 immunization for, 37 treatment and prevention of, YF. See Yellow fever.

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Adaptive immune response biologic response modifiers and, 735 737 S-Adenosylmethionine (SAMe) for hepatitis, 825 826 Albinterferon for hepatitis,